Spectrum Solutions® Unveil Simply PERIO™ Saliva Test with Simply Test® Power

Spectrum Solutions®, a leading saliva diagnostic biotech company, has launched SimplyPERIO™, a new saliva diagnostic testing solution. This innovative test addresses the growing focus on the mouth-body connection and its impact on overall health. SimplyPERIO™ offers comprehensive health insights by…

Read MoreSpectrum Solutions® Unveil Simply PERIO™ Saliva Test with Simply Test® Power

Samsung Receives Healthcare Innovator Award for Underserved Communities Care

Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound division, received HHM Health’s Healthcare Innovator Award for its SonoSync technology and efforts to improve healthcare access for underserved communities. The award was accepted during HHM Health’s Healing Hands…

Read MoreSamsung Receives Healthcare Innovator Award for Underserved Communities Care

IIPA Boosts Antibody Discovery with Carterra LSA® Instrument Acquisition

IPA (IMMUNOPRECISE ANTIBODIES LTD.) (NASDAQ: IPA), a biotherapeutics research and technology company driven by artificial intelligence, has acquired Carterra’s LSA® instrument platform. This high-throughput screening and characterization solution enhances IPA’s capabilities in antibody characterization through surface plasmon resonance, enabling advanced…

Read MoreIIPA Boosts Antibody Discovery with Carterra LSA® Instrument Acquisition

Bristol Myers Squibb’s Abecma: First CAR T Cell Therapy Approved in EU for Multiple Myeloma

Bristol Myers Squibb (NYSE: BMY) has announced that the European Commission (EC) has granted approval to Abecma® (idecabtagene vicleucel; ide-cel) for treating adult patients with relapsed and refractory multiple myeloma who have undergone at least two prior therapies, including specific…

Read MoreBristol Myers Squibb’s Abecma: First CAR T Cell Therapy Approved in EU for Multiple Myeloma